NovoCure (NVCR) Other Accumulated Expenses (2014 - 2018)

NovoCure (NVCR) has reported Other Accumulated Expenses for 5 consecutive years, with $32000.0 the latest figure, recorded in Q4 2018.

• Quarterly Other Accumulated Expenses fell 77.78% year-over-year to $32000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $32000.0 (down 77.78% YoY) and the FY2018 annual result came in at $32000.0, down 77.78% from the prior year.
• Other Accumulated Expenses slipped to $32000.0 in Q4 2018 per NVCR's latest filing, from $144000.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for NVCR reached as high as $712000.0 in Q4 2015 and fell as low as $32000.0 in Q4 2018.
• A 5-year average of $212200.0 and a median of $97000.0 in 2014 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2015 — Other Accumulated Expenses surged 634.02% — and 2016, when it tumbled 89.33%.
• Year by year, Other Accumulated Expenses stood at $97000.0 in 2014, then jumped by 634.02% to $712000.0 in 2015, then slumped by 89.33% to $76000.0 in 2016, then soared by 89.47% to $144000.0 in 2017, then plunged by 77.78% to $32000.0 in 2018.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $32000.0, $144000.0, and $76000.0 for Q4 2018, Q4 2017, and Q4 2016 respectively.